Torrent Pharma Q1 net profit up 2.8% at Rs330cr as India business shows strong 18% growth
Torrent Pharma Ltd reported 3.79% growth yoy in total sales revenues for the Jun-21 quarter on consolidated basis at Rs2,134cr July 28, 2021 8:04 IST | India Infoline News Service
Torrent Pharma Ltd reported 3.79% growth yoy in total sales revenues for the Jun-21 quarter on consolidated basis at Rs2,134cr. On a sequential basis, the revenues were up 10.17% compared to Rs1,937cr in the Mar-21 quarter showing limited COVID impact. During the quarter, Torrent Pharma launched anti-COVID drug, Bariticinib, which is currently under clinical trials for Molnupiravir. On a yoy basis, the India revenues showed 18% growth at Rs1,093cr. Ho
Maintain ADD on Torrent Pharma - In-line quarter; positive outlook reaffirmed - HDFC Securities
equitybulls.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from equitybulls.com Daily Mail and Mail on Sunday newspapers.
Market ahead: Ahead of Market: 12 things that will decide stock action on Thursday
indiatimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from indiatimes.com Daily Mail and Mail on Sunday newspapers.
BSE NSE Sensex Today, Stock Market Latest Update: July 27 Share Market, Trade BSE, Nifty, Sensex Live News Updates | ऊंचे स्तरों पर बिकवाली से शुरुआती बढ़त गायब, सेंसेक्स 52,900 और निफ्टी 15,850 के पास; मेटल और रियल्टी शेयरों में खरीदारी
bhaskar.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bhaskar.com Daily Mail and Mail on Sunday newspapers.